Lily Arya, MD
Urogynecology and Reconstructive Pelvic Surgery · Philadelphia, PANPI 1780612804
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,410 of the $34,398 with a category attached, or 73.9%. 4 manufacturers reported payments, led by Urovant Sciences Inc at 57.6% of the total. Reporting peaked in 2023 at $14,556 and has fallen 99.9% since, to $14 in 2024. Among urogynecology and reconstructive pelvic surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $1042.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urovant Sciences Inc$20K
- Sumitomo Pharma America, Inc.$15K
- AbbVie$21
- Hologic Sales And Service, LLC$14
Across 31 payments — averaging $5873.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson$182K
What the payments were for
- Consulting fees$3,0809%
- Speaking & faculty fees$25,41074%
- Travel & lodging$5,25715%
- Food & beverage$6272%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urovant Sciences Inc | 15 | $19,806 |
| Sumitomo Pharma America, Inc. | 16 | $14,556 |
| AbbVie | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GEMTESA$34,139
How this compares
$34,398 in reported general payments places this provider in the 90th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.
See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 64 | $55,685 |
| GemtesaVibegron | 19 | $12,986 |
| Estradiol | 127 | $8,519 |
| PremarinEstrogens, Conjugated | 15 | $6,347 |
| YuvafemEstradiol | 29 | $4,197 |
| Methenamine Hippurate | 18 | $1,704 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 72 | $735 |
| Trospium Chloride | 18 | $490 |
| Ibuprofen | 43 | $116 |
| Ciprofloxacin Hcl | 30 | $115 |
| Oxycodone Hcl | 27 | $84 |
| Cephalexin | 20 | $62 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $14,556 | $12,98619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.
Other urogynecology and reconstructive pelvic surgery in Philadelphia
- Whitney SmithPhiladelphia$3K
- Heidi HarviePhiladelphia$3K
- Alana MurphyPhiladelphia$2K
- Sonia BhandariPhiladelphia$1K
- Carol GlowackiPhiladelphia$1K
- Pamela LevinPhiladelphia$47
- Vincent LucenteAllentown$798K
- Miles MurphyAllentown$54K
- Heather GottliebNewtown$48K
- Michael BonidieMechanicsburg$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.